Vasculoprotective effects of LEX-032, a novel recombinant serpin, during splanchnic ischemia and reperfusion

Cardiovascular Pathobiology

Volumn 2, Issue 3-4, 1997, Pages 191-198

  Hayward, Reid ^b   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

Endothelial dysfunction; Mean arterial blood pressure; Myeloperoxidase activity; Superior mesenteric artery; Survival time

Indexed keywords

ACETYLCHOLINE; LEX 032; MYELOPEROXIDASE; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

EID: 0031295623     PISSN: 10887180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Johnson KJ, Varani J, Smolen JE: Neutrophil activation and function in health and disease. In: Granulocyte Response to Cytokines, ed. Coffey RG. New York: Dekker, 1992; 1-46.
2. Lefer AM, Tsao P, Aokí N, and Palladino MA, Jr.: Mediation of cardioprotection by transforming growth factor-β. Science 1990; 249:61-64.
3. Weyrich AS, Ma X-L, Lefer DJ, Albertine KH, Lefer AM: In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91:2620-2629.
4. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL: The cytokine-adhesion molecule cascade in ischemia/ reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99:2682-2690.
5. Davenpeck KL, Gauthier TW, Albertine KH, Lefer AM: Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 1994; 267:H622-H630.
6. Granger DN, Benoit JN, Suzuki M, Grisham MB: Leukocyte adherence to vascular endothelium during ischemia-reperfusion. Am J Physiol 1989; 257:G683-G688.
7. Kurtel H, Tso P, Granger DN: granulocyte accumulation in postischemic intestine: role of leukocyte adhesion glycoprotein CD11/CD18. Am J Physiol 1992; 262:G878-G882.
8. Oliver MG, Specian RD, Perry MA, Granger DN: Morphological assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation 1991; 15:331-346.
9. Sands H, Hook JB: Pharmacology and pharmacokinetics of LEX-032, a bioengineered serpin: The first of a potential new class of drugs. Drug Metab Rev 1997; 29:309-328.
10. Buerke M, Weyrich AS, Lefer AM: Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil released mediators. Am J Physiol 1994; 266:H128-H136.
11. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376.
12. Rubin H, Plotnick M, Wang Z, Liu X, Zhong Q, Schlechter NM, Cooperman BS: Conversion of a1-anti-chymotrypsin into a human neutrophil elastase inhibitor: Demonstration of variants with different association rate constants, stoichiometries of inhibition, and complex stabilities. Biochemistry 1994; 33:7627-7633.
13. Delyani JA, Murohara T, Lefer AM: Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in cats. Am J Physiol 1995; 270:H881-H887.
14. Murohara T, Guo J-P, Lefer AM: Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J Pharm Exp Ther 1995; 274:1246-1253.
15. Scalia R, Gauthier TW, Lefer AM: Beneficial effects of LEX-032, a novel recombinant serine protease inhibitor, in murine traumatic shock. Shock 1995; 4:251-256.
16. Bradley PP, Priebat DA, Christensen RD, Rohstein GR: Measurement of cutaneous inflammation: Estimation of the neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-209.
17. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 1985; 14:157-167.
18. Yuan Y, Fleming BP: A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvasc Res 1990; 40:218-229.
19. Knapp RG, Wise WC: A more appropriate statistical method for analyzing mortality data in shock research. Circ Shock 1985; 16:375-381.
20. Grisham MB, Hernandez LA, Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251:G456-G462.
21. Lefer AM, Barenholz Y: Pancreatic hydrolases and the formation of a myocardial depressant factor in shock. Am J Physiol 1972; 223:1103-1109.
22. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-1036.
23. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994; 93:1140-1148.
24. Lefer AM, Tsao PS, Lefer DJ: Ma X-1: Role of endothelial dysfunction in the pathogenesis of reperfusion injury following myocardial ischemia. FASEB J 1991; 5:2029-2034.
25. Lefer AM, Lefer DJ: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993; 33:71-90.
26. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J: Anti-neutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993; 88:2337-2350.
27. Carey C, Siegfried MR, Ma X-1, Weyrich AS, Lefer AM: Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock 1992; 38:209-216.
28. 4 antagonist in splanchnic ischemia and reperfusion in rats. Am J Physiol 1991; 261:G191-G198.
29. Hynes RO: Integrins: A family of cell surface receptors. Cell 1987; 48:549-554.
30. Zimmerman BJ, Granger DN: Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 1990; 259:H390-H394.
31. Rice WG, Weiss SJ: Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science Wash, DC 1990; 249:178-181.
32. Boudier C, Holle C, Bieth JG: Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J Biol Chem 1981; 256:10256-10258.
33. 4 and platelet-activating factor. Eur J Biochem 1989; 182:661-666.
34. Suzuki M, Inauen W, Kvietys PR, Grisham MB, Meininger C, Schelling ME, Granger HJ, Granger DN: Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol 1989; 257:H1740-H1745.
35. Johnston B, Kanwar S, Kubes P: Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am J Physiol 1996; 271: H614-H621.
36. Huie RE, Padmaja S: The reaction of NO with superoxide. Free Radic Res Commun 1993; 18:195-199.
37. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker-Botelho LH: Cytoprotective function of nitric oxide: Inactivation of Superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991; 181:1392-1397.
38. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone Jr. MA, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation. Nitric Oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-68.
39. Armstead VE, Minchenko AG, Schuhl RA, Hayward R, Nossuli TO, Lefer AM: Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol 1997; 42:H740-H746.
40. Schuster MG, Enruquez PM, Currant P, Cooperman BS, Rubin H: Regulation of neutrophil superoxide by anti-chymotrypsin-chymotrypsin complex. J Biol Chem 1992; 137:962-970.